Clinical science of Helicobacter pylori infection: Ulcers and NSAIDs

British Medical Bulletin

Volumn 54, Issue 1, 1998, Pages 55-62

  Calam, John ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; BISMUTH; MISOPROSTOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; RANITIDINE;

ANTIMICROBIAL THERAPY; CLINICAL TRIAL; DIARRHEA; DRUG WITHDRAWAL; DUODENUM ULCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 0031905270     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011679     Document Type: Review

References (38)

1. Brinton W. On the Pathology, Symptoms and Treatment of Ulcer of the Stomach. London: Churchill, 1867
2. Anonymous. A post mortem study of gastric and duodenal peptic lesions. Gut 1963; 4: 349-59
3. Watkinson G. The incidence of chronic peptic ulcer found at necropsy. Gut 1960; 1: 14-31
4. Langman MJS. The Epidemiology of Chronic Digestive Disease. London: Arnold, 1979
5. Susser S, Stein K. Civilisation and peptic ulcer. Lancet 1962; 1: 115-8
6. Ihamaki T, Varis K, Siurala M. Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families. Comparison with a computer-matched family sample. Scand J Gastroenterol 1979; 14: 801-12
7. Bonnevie O. The incidence of duodenal ulcer in Copenhagen county. Scand J Gastroenterol 1975; 10: 385-93
8. Martin DF, Hollanders D, May SJ, Ravenscroft MM, Tweedle DE, Miller JP. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet 1981; 1: 7-10
9. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-5
10. Marshall BJ, Goodwin CS, Warren JR et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437-42
11. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233-5
12. Tytgat G, Dixon M. Role in peptic ulcer disease: overview. In: Northfield TC, Mendall M, Goggin PM. eds. Helicobacter pylori infection. Lancaster: Kluwer, 1993; 75-87
13. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 1244-52
14. McColl KE, el Nujumi AM, Chittajallu RS et al. A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulceration. Gut 1993; 34: 762-8
15. 2-receptor antagonists. Gastroenterology 1996; 110: A137
16. Bonnevie O. The incidence of gastric ulcer in Copenhagen county. Scand J Gastroenterol 1975; 10: 231-9
17. Lambert JR, Lin SK. Prevalence/disease correlates of H. pylori. In: Hunt RH, Tytgat GNJ. eds. Helicobacter pylori: Basic Mechanisms to Clinical Cure. Dorcrecht: Kluwer, 1994; 95-112
18. Lanas AI, Remacha B, Esteva F, Sainz R. Risk factors associated with refractory peptic ulcers. Gastroenterology 1995; 109: 1124-33
19. Graham DY, Lew GM, Klein PD et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992; 116: 705-8
20. Karita M, Morshed MG, Ouchi K, Okita K. Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate. Am J Gastroenterol 1994; 89: 1032-5
21. Bayerdorffer E, Miehlke S, Lehn N et al. Cure of gastric ulcer disease after cure of Helicobacter pylori infection - German Gastric Ulcer Study. Eur J Gastroenterol Hepatol 1996; 8: 343-9
22. Labenz J, Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994; 35: 19-22
23. Kihira K, Sato K, Yoshida Y, Takimoto T, Taniguchi Y, Kimura K. The effect of the eradication of H. pylori on the intractable ulcer. Nippon Rinsho 1993; 51: 3285-8
24. Laine LA. Helicobacter pylori and complicated ulcer disease. Am J Med 1996; 100: 52S-57S
25. Labenz J, Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55 19-23
26. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993; 28: 939-42
27. Reinbach DH, Cruickshank G, McColl KE. Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 1993; 34: 1344-7
28. Debongnie JC, Wibin E, Timmermans M, Mairesse J, Dekoninck X. Are perforated gastroduodenal ulcers related to Helicobacter pylon infection?. Acta Gastroenterol Belg 1995; 58: 208-12
29. Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers. BMJ 1990; 300: 278-84
30. Griffin MR, Piper JM, Daugherty JR, Snowdcn M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257-63
31. Lipscomb GR, Wallis N, Armstrong G, Goodman MJ, Rees WD. Influence of Helicobacter pylori on gastric mucosal adaptation to naproxen in man. Dig Dis Sci 1996; 41: 1583-8
32. Porro GB, Parente F, Imbesi V, Montrose F, Caruso I. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users: response to omeprazole dual therapy. Gut 1996; 39: 22-26
33. Chan FKL, Sung JY, Leung VKS et al. Does eradication of H. pylori prevent NSAID-induced ulcers [Abstract]? Gastroenterology 1996; 110 (Suppl.): A79
34. Hawkey CJ. Are NSAIDs and Helicobacter pylori separate risk factors. In: Hunt RH, Tytgat GNJ. eds. Helicobacter pylori - Basic Mechanisms to Clinical Cure 1996. Dordrecht: Kluwer, 1996; 312-23
35. Tildesley G, Ehsanullah RS, Wood JR. Ranitidine in the treatment of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drugs. Br J Rheumatol 1993; 32: 474-8
36. Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study. Am J Gastroenterol 1996; 91: 223-7
37. Ekstrom P, Carling L, Wetterhus S et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non steroidal anti inflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol 1996; 31: 753-8
38. Chan CC, Boyce S, Brideau C et al. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745, 337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther 1995; 274: 1531-7